Skip to main content
For professional inquiries, please contact us: reynolds_science_inquiries@rjrt.com
Reynolds Science REYNOLDS - A Better Tomorrow - Logo
  • Tobacco Harm Reduction
  • Smokeless Products
  • Our Science
    • Framework
    • Analytical Science
    • Pre-Clinical
    • Individual Health
    • Population Health
  • Let’s Connect
    • Conferences
  • Library
  • Tobacco Harm Reduction
  • Smokeless Products
  • Our Science
    • Framework
    • Analytical Science
    • Pre-Clinical
    • Individual Health
    • Population Health
  • Let’s Connect
    • Conferences
  • Library
For professional inquiries, please contact us: XXXX@BAT.COM
science

Individual & Population Health

file icon
Nov 30th 2022

Part three: a randomized study to assess biomarker changes in cigarette smokers switched to Vuse Solo or Abstinence

file icon
Aug 19th 2022

Designing Studies to Inform Tobacco Harm Reduction: Learnings From an Oral Nicotine Pouch Actual Use Pilot Study

file icon
Nov 27th 2021

Reporting and methodological quality of systematic literature reviews evaluating the associations between e-cigarette use and cigarette smoking behaviors: a systematic quality review

file icon
Sep 9th 2021

Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations

file icon
May 21st 2021

Differences in biomarkers of inflammation and immune responses in chronic smokers and moist snuff users

file icon
Oct 20th 2020

Metabolomics analysis indentified reduced levels of xenobiotics, oxidative stress, and improved vitamin metabolism in smokers switched to an Electronic Nicotine Delivery Device System

file icon
Jan 24th 2020

Assessing comprehension and perceptions of modified-risk information for snus among adult current cigarette smokers, former tobacco users, and never tobacco users

file icon
Oct 22nd 2019

Urinary leukotriene E4 and 2,3-dinor thromboxane B2 are potential biomarkers of effect in short-term tobacco switching studies

file icon
Jun 6th 2019

Investigation of multiple whole smoke dosimetry techniques using a VITROCELL®VC10® smoke exposure system

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
Reynolds Science REYNOLDS - A Better Tomorrow - Logo

© 2026 RAISC.

This website is intended for scientists and policymakers. The material on this website is not provided for product advertising, promotional, or marketing purposes. We encourage persons interested in tobacco harm reduction to consider all points of view and sources of information. The Reynolds American organization does not make health claims regarding its companies’ brands. Nothing contained here should be misconstrued to the contrary. To the extent that third-party sources are referenced, the Reynolds American organization is not responsible for the content of referenced sources and the views expressed may not represent the views of the Reynolds American organization. No tobacco product is safe, all tobacco products containing nicotine are addictive. Underage persons should never use tobacco. Smokers who are concerned about their health should quit.

Reynolds American Inc. is the U.S. parent company of, among others, R. J. Reynolds Tobacco Company; Santa Fe Natural Tobacco Company, Inc.; American Snuff Company, LLC; R. J. Reynolds Vapor Company; Modoral Brands Inc.; RAI Services Company; and Reynolds Marketing Services Company. All subsidiaries operate and conduct separate, distinct businesses. References to “Reynolds,” “the group,” “the company,” “the organization,” “we,” “us,” and “our” are simply for convenience and may be used to refer to Reynolds American Inc. and/or one of its independent subsidiary operating companies, collectively or individually, and are not intended to imply or suggest that the subsidiaries’ businesses are operated other than as separate, distinct businesses. Activities among affiliate companies are covered through intercompany services agreements with arm's-length terms and conditions.

  • Terms of Use
  • Member of the Global BAT Group